Association between use of psychotropic medications prior to SARS-COV-2 infection and trajectories of COVID-19 recovery: Findings from the prospective Predi-COVID cohort study DOI Creative Commons
Gloria Aguayo, Aurélie Fischer, Abir Elbéji

et al.

Frontiers in Public Health, Journal Year: 2023, Volume and Issue: 11

Published: March 16, 2023

Psychological disturbances are frequent following COVID-19. However, there is not much information about whether pre-existing psychological disorders associated with the severity and evolution of We aimed to explore associations between regular psychotropic medication use (PM) before infection as a proxy for mood or anxiety COVID-19 recovery trajectories. used data from Predi-COVID study. followed adults, tested positive SARS-CoV-2 collected demographics, clinical characteristics, comorbidities daily symptoms 14 days after inclusion. calculated score based on 16 modeled latent class performed polynomial logistic regression PM primary exposure different trajectories outcome. included 791 participants, 51% were men, 5.3% reported infection. identified four characterizing dynamics: "Almost asymptomatic," "Quick recovery," "Slow "Persisting symptoms". With fully adjusted model age, sex, socioeconomic, lifestyle comorbidity, we observed risks being in more severe than Asymptomatic": recovery" (relative risk (95% confidence intervals) 3.1 (2.7, 3.4), 5.2 (3.0, 9.2), symptoms"11.7 (6.9, 19.6) gradient slow no first days. These results suggest that condition increases poorer may increase Long COVID. Our findings can help personalize care people

Language: Английский

Skeletal Muscle and COVID-19: The Potential Involvement of Bioactive Sphingolipids DOI Creative Commons
Elisabetta Meacci, Federica Pierucci, Mercedes Garcia‐Gil

et al.

Biomedicines, Journal Year: 2022, Volume and Issue: 10(5), P. 1068 - 1068

Published: May 4, 2022

SARS-CoV-2 virus infection is the cause of coronavirus disease 2019 (COVID-19), which still spreading over world. The manifestation this can range from mild to severe and be limited in time (weeks) or persist for months about 30–50% patients. COVID-19 considered a multiple organ dysfunction syndrome musculoskeletal system manifestations are beginning absolute importance both patients recovering infection. Musculoskeletal other infections include loss muscle mass, weakness, fatigue myalgia, injury. molecular mechanisms by damage skeletal (SkM) cells not yet well understood. Sphingolipids (SLs) represent an important class eukaryotic lipids with structural functions as bioactive molecules able modulate crucial processes, including inflammation viral In last two decades, several reports have highlighted role SLs modulating SkM cell differentiation, regeneration, aging, response insulin, contraction. This review summarizes consequences on potential involvement tissue responses particular, we highlight sphingosine 1-phosphate signaling order aid prediction novel targets preventing and/or treating acute long-term COVID-19.

Language: Английский

Citations

9

Comorbidity Patterns and Mortality Among Hospitalized Patients with Psychiatric Disorders and COVID-19 DOI Creative Commons
Marina Sánchez‐Rico, Katayoun Rezaei, Alfonso Delgado‐Álvarez

et al.

Brazilian Journal of Psychiatry, Journal Year: 2023, Volume and Issue: unknown

Published: Jan. 1, 2023

To examine the association between psychiatric and non-psychiatric comorbidity 28-day mortality among patients with disorders COVID-19.We performed a multicenter observational retrospective cohort study of adult hospitalized laboratory-confirmed COVID-19 at 36 Greater Paris University hospitals (January 2020-May 2021) (N=3,768). First, we searched for different subgroups according to their comorbidities through cluster analysis. Next, compared all-cause rates across identified clusters, while taking into account sex, age, number medical conditions.We found 5 clusters distinct patterns. Twenty-eight-day in mood was significantly lower than other clusters. There were no significant differences clusters.All conditions may be associated increased COVID-19. The risk death might line potential beneficial effect certain antidepressants COVID-19, but requires further research. These findings help identify at-risk who should benefit from vaccine booster prioritization prevention measures.

Language: Английский

Citations

4

Antipsychotic use and 28-day mortality in patients hospitalized with COVID-19: A multicenter observational retrospective study DOI Creative Commons
Marina Sánchez‐Rico,

Alejandro Edán-Sánchez,

Mark Olfson

et al.

European Neuropsychopharmacology, Journal Year: 2023, Volume and Issue: 75, P. 93 - 104

Published: June 16, 2023

Language: Английский

Citations

4

Psychopharmacotherapy factor in the variants of COVID-19 course in psychiatric inpatients DOI Creative Commons
Н. Г. Незнанов, О. В. Лиманкин, A. V. Shabelnik

et al.

V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY, Journal Year: 2024, Volume and Issue: 58(2), P. 79 - 88

Published: April 25, 2024

The aim of this study is to examine the relationship between severity and duration criteria COVID-19 psychopharmacotherapy administered patients in within a psychiatric hospital. Materials Methods. We analyzed 169 case histories involving completed clinical cases treatment specialized infectious department St. Petersburg, covering period from May 2020 January 2021. Correlation, dispersion, regression analyses were employed evaluate severe mild progression indicators, as well persistent SARS-CoV-2 viral shedding. assessed laboratory parameters patients, along with administered, including antidepressants, antipsychotics, acid sphingomyelinase inhibitors (FIASMA-active drugs). Results. Cardiovascular diseases emerged predictor when combined an increasing platelet-to-lymphocyte ratio (PLR), risk course by over two-fold. use any psychotropic agents was associated 0.9% increase for each unit systemic inflammation index PLR, specifically intellectual disability (ICD-10 codes F70-79), compared schizophrenia F20-29). High PLR values FIASMA-active drugs prolonged duration, while antidepressant therapy elevated C-reactive protein levels reduced predicted shedding 13.8% variance. Additional consideration nosology disorders model increased proportion explained variance 22.8%. Conclusion. Consideration should be given thymoanaleptic individuals during periods disease incidence leading up potential infection, it may serve protective factor against COVID-19. Furthermore, there no evidence suggest adverse effects antipsychotics on Further research required investigate psychopharmacological nosologically homogeneous groups.

Language: Английский

Citations

1

Association between use of psychotropic medications prior to SARS-COV-2 infection and trajectories of COVID-19 recovery: Findings from the prospective Predi-COVID cohort study DOI Creative Commons
Gloria Aguayo, Aurélie Fischer, Abir Elbéji

et al.

Frontiers in Public Health, Journal Year: 2023, Volume and Issue: 11

Published: March 16, 2023

Psychological disturbances are frequent following COVID-19. However, there is not much information about whether pre-existing psychological disorders associated with the severity and evolution of We aimed to explore associations between regular psychotropic medication use (PM) before infection as a proxy for mood or anxiety COVID-19 recovery trajectories. used data from Predi-COVID study. followed adults, tested positive SARS-CoV-2 collected demographics, clinical characteristics, comorbidities daily symptoms 14 days after inclusion. calculated score based on 16 modeled latent class performed polynomial logistic regression PM primary exposure different trajectories outcome. included 791 participants, 51% were men, 5.3% reported infection. identified four characterizing dynamics: "Almost asymptomatic," "Quick recovery," "Slow "Persisting symptoms". With fully adjusted model age, sex, socioeconomic, lifestyle comorbidity, we observed risks being in more severe than Asymptomatic": recovery" (relative risk (95% confidence intervals) 3.1 (2.7, 3.4), 5.2 (3.0, 9.2), symptoms"11.7 (6.9, 19.6) gradient slow no first days. These results suggest that condition increases poorer may increase Long COVID. Our findings can help personalize care people

Language: Английский

Citations

2